Efficacy News and Research

RSS
Article related to MN-166 mechanism of action included in PNAS USA

Article related to MN-166 mechanism of action included in PNAS USA

Optics Express publishes special focus issue on lung cancer imaging research

Optics Express publishes special focus issue on lung cancer imaging research

Silence strengthens RNAi IP portfolio with issuance of key patent in structural modification technology

Silence strengthens RNAi IP portfolio with issuance of key patent in structural modification technology

Researchers evaluate safety and feasibility of STARR procedure for ODS

Researchers evaluate safety and feasibility of STARR procedure for ODS

Ethicon launches OMNEX Surgical synthetic sealant

Ethicon launches OMNEX Surgical synthetic sealant

Landmark study compares oral and transvaginal NOTES to traditional laparoscopy

Landmark study compares oral and transvaginal NOTES to traditional laparoscopy

FDA-approved bioidentical estrogens help women manage common symptoms of menopause

FDA-approved bioidentical estrogens help women manage common symptoms of menopause

Clinical performance data of Cervista HPV HR presented at International Papillomavirus Conference

Clinical performance data of Cervista HPV HR presented at International Papillomavirus Conference

Seattle non-profit recommends 'national strategy' for improving U.S. foreign aid efficacy

Seattle non-profit recommends 'national strategy' for improving U.S. foreign aid efficacy

Review examines surgical and non-surgical treatments available for patients with knee arthritis

Review examines surgical and non-surgical treatments available for patients with knee arthritis

GSK, XenoPort disappointed with GSK1838262/XP13512 phase 2b study for migraine headaches

GSK, XenoPort disappointed with GSK1838262/XP13512 phase 2b study for migraine headaches

Crooks defraud health care system with fake insurance plans and phony Medicare, Medicaid claims

Crooks defraud health care system with fake insurance plans and phony Medicare, Medicaid claims

ISCO and Sankara Nethralaya collaborate to develop "CytoCor" stem cell-derived corneal tissue

ISCO and Sankara Nethralaya collaborate to develop "CytoCor" stem cell-derived corneal tissue

PolyMedix receives NIH grant to develop defensin-mimetic antimicrobial compounds for malaria

PolyMedix receives NIH grant to develop defensin-mimetic antimicrobial compounds for malaria

Epeius Biotechnologies receives notice of allowance from USPTO for gene delivery platform

Epeius Biotechnologies receives notice of allowance from USPTO for gene delivery platform

European Commission approves new indication for ORENCIA in combination with MTX for RA

European Commission approves new indication for ORENCIA in combination with MTX for RA

Molecular Templates enters into oncology drug discovery and translation research agreement with ImClone

Molecular Templates enters into oncology drug discovery and translation research agreement with ImClone

Initial Phase II study results of ofatumumab in patients with RRMS announced

Initial Phase II study results of ofatumumab in patients with RRMS announced

MJFF teams up with EHE International to raise awareness of Parkinson's disease

MJFF teams up with EHE International to raise awareness of Parkinson's disease

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.